These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3297285)

  • 1. Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation.
    Shipley WU; Prout GR; Kaufman SD; Perrone TL
    Cancer; 1987 Aug; 60(3 Suppl):514-20. PubMed ID: 3297285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment strategies using transurethral surgery, chemotherapy, and radiation therapy with selection that safely allows bladder conservation for invasive bladder cancer.
    Kanady KE; Shipley WU; Zietman AL; Kaufman DS; Althausen AF; Heney NM
    Semin Surg Oncol; 1997; 13(5):359-64. PubMed ID: 9259092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of long-term treatment of inoperable cancer of the bladder with cisplatin and concurrent irradiation: prognostic factors of local control and survival].
    Chauvet B; Félix-Faure C; Davin JL; Choquenet C; Alfonsi M; Reboul F
    Cancer Radiother; 1998 Apr; 2 Suppl 1():85s-91s. PubMed ID: 9749086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder cancer. The selection of patients for treatment by full-dose irradiation.
    Shipley WU; Rose MA
    Cancer; 1985 May; 55(9 Suppl):2278-84. PubMed ID: 3919933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.
    Cole CJ; Pollack A; Zagars GK; Dinney CP; Swanson DA; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):331-40. PubMed ID: 7751174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder.
    Mameghan H; Fisher R; Mameghan J; Brook S
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):247-54. PubMed ID: 7836076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder preservation by combined modality therapy for invasive bladder cancer.
    Kachnic LA; Kaufman DS; Heney NM; Althausen AF; Griffin PP; Zietman AL; Shipley WU
    J Clin Oncol; 1997 Mar; 15(3):1022-9. PubMed ID: 9060542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
    Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
    J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral resection for muscle-invasive bladder cancer.
    Kondás J; Váczi L; Szecsó L; Kondér G
    Int Urol Nephrol; 1993; 25(6):557-63. PubMed ID: 8175277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies.
    Richards KA; Smith ND; Steinberg GD
    J Urol; 2014 Jun; 191(6):1655-64. PubMed ID: 24518761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radical cystectomy in the treatment of bladder cancer always in due time?].
    May M; Braun KP; Richter W; Helke C; Vogler H; Hoschke B; Siegsmund M
    Urologe A; 2007 Aug; 46(8):913-9. PubMed ID: 17676301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent cisplatin and radiotherapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy.
    Chauvet B; Brewer Y; Félix-Faure C; Davin JL; Choquenet C; Reboul F
    J Urol; 1996 Oct; 156(4):1258-62. PubMed ID: 8808849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival.
    Shipley WU; Rose MA; Perrone TL; Mannix CM; Heney NM; Prout GR
    J Urol; 1985 Oct; 134(4):679-83. PubMed ID: 4032570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
    Pansadoro V; Emiliozzi P
    Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infiltrating transitional carcinoma of the bladder (I). Comparison of 2 groups treated with preoperative radiotherapy (long-term protocol and short-term protocol) + radical cystectomy versus radical cystectomy only. Analysis of local recurrence and metastasis].
    Escudero Barrilero A; Allona A; Berenguer A; Burgos J; Castañeda A; Negrin A; Tellez M
    Actas Urol Esp; 1991; 15(2):124-38. PubMed ID: 1807106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organ preservation in muscle-invasive bladder cancer.
    Fernando SA; Sandler HM
    Oncology (Williston Park); 2005 Mar; 19(3):334-9; discussion 339-40, 345, 349, 350-3. PubMed ID: 15828550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
    George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
    Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
    Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
    Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.